A new online learning series for ERN professionals, clinicians, researchers, and stakeholders.

Advancing Rare Disease Diagnostics: The ERDERA Diagnostic Research Workstream Webinar Series

ERDERA trainings diagnostics

As part of its Education and Training offering, ERDERA is launching a dedicated webinar series designed to inform and engage the wider rare disease community: the ERDERA Diagnostic Research Workstream Webinar Series.

About the series

The series brings together ERN healthcare professionals, clinicians, geneticists, researchers, and other stakeholders to learn about the work, progress, and outcomes of the ERDERA Diagnostic Research Workstream (DRW).

Sessions will cover the full scope of the workstream — from governance and methodology to concrete analytical results — offering audiences a transparent and evolving view of how ERDERA is advancing diagnostics in rare diseases.

Delivered as online webinars, the series is accessible to both internal ERN audiences and external expert communities, reflecting ERDERA’s commitment to open knowledge-sharing and collaboration across borders.

What to expect

Eight webinars are planned between May 2026 and June 2027, each focused on a distinct aspect of the Diagnostic Research Workstream:

ERDERA Diagnostic Research Workstream Webinar Series — planned sessions
# Title Topic Speakers Date Event link
1
The ERDERA Diagnostic Research Workstream – An Overview
General overview of the DRW Holm Graessner 28 May 2026 View event
2 Data sharing, data management & ethics DSFA, ethics, data submission, data flow, RD3 Kornelia Ellwanger, Leslie Matalonga 25 September 2026 Register here
3 The data reanalysis approach of the Diagnostic Research Workstream Tiered approach, DITF-DATF structure, Solvathon concept Lisenka Vissers October 2026 Link coming soon
4 Long-read sequencing and Optical Genome Mapping WP8 long-read sequencing and OGM Bart van der Sanden, Alexander Hoischen, Stephan Ossowski / Tobias Haack (tbc) December 2026 Link coming soon
5 Results of the systematic reanalysis Results of data reanalysis Tier 1 Sergi Beltran, Gemma Bullich, Lisenka Vissers February 2027 Link coming soon
6 First results from our innovative reanalysis approach Results of data reanalysis Tier 2 Sergi Beltran, Gemma Bullich April 2027 (tbc) Link coming soon
7 Scaling-up: from distributed to federated reanalysis Distributed vs. federated approach Sergi Beltran, Morris Swertz, Julien Thevenon (tbc) May 2027 Link coming soon
8 Reanalysis of RNAseq data RNAseq reanalysis results Vicente Yépez June 2027 Link coming soon

Note: Dates marked (tbc) are preliminary and subject to change.

Themes at a glance

Across the eight sessions, the series traces the full arc of the Diagnostic Research Workstream’s activities. Early webinars introduce governance structures, ethical frameworks, and data management principles. Middle sessions delve into methodological innovation — including tiered reanalysis strategies, long-read sequencing, and optical genome mapping. Later webinars focus on results, first from systematic Tier 1 reanalysis and then from more advanced approaches.

Details on registration and attendance of each of the webinar will be made available through ERDERA’s official channels, including this page, closer to the date.

News & Updates

You might also be interested in

This free online session will highlight patient and research perspectives, innovative clinical study methods, and emerging regulatory approaches
September 30 @ 1:00 pm - 2:00 pm
This ERDERA webinar will provide an overview of the regulatory and ethical requirements for advanced therapy medicinal product (ATMP) research, with a particular focus on genome editing and paediatric studies in rare diseases.
October 21 @ 2:30 pm - 5:30 pm
A special anniversary event showcasing how innovation, collaboration and novel trial methodologies are advancing rare disease research.
Applications for the 2027 Open Academy x ERDERA Schools offer patient advocates and early-career researchers the opportunity to strengthen their knowledge and participation in rare disease research.